4.6 Article

New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Cardiac & Cardiovascular Systems

Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?

Franz H. Messerli et al.

CIRCULATION (2022)

Review Medicine, General & Internal

Aspirin Use to Prevent Cardiovascular Disease US Preventive Services Task Force Recommendation Statement

Karina W. Davidson et al.

Summary: Cardiovascular disease is the leading cause of death in the US, and aspirin is used for the prevention of cardiovascular disease. According to the latest recommendations from the US Preventive Services Task Force, low-dose aspirin use has a small net benefit for adults aged 40 to 59 years with a 10% or greater 10-year cardiovascular disease risk. However, there is no net benefit from initiating low-dose aspirin use for adults aged 60 years or older.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Multidisciplinary Sciences

Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials

Ilke Sipahi

Summary: This analysis reveals for the first time that the risk of cancer, especially lung cancer, increases with increasing cumulative exposure to ARBs. The long-term use of ARBs has significant implications on public health.

PLOS ONE (2022)

Article Medicine, General & Internal

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)

Jordana B. Cohen et al.

Summary: This observational cohort study aimed to evaluate the cognitive outcomes of individuals at risk for mild cognitive impairment and probable dementia after initiating an ARB- vs ACEI-based antihypertensive regimen. The study found no significant difference in the rate of amnestic MCI or PD among new users of ARB compared with ACEI.

JAMA NETWORK OPEN (2022)

Article Medicine, General & Internal

The Impact of Different Antihypertensive Drugs on Cardiovascular Risk in Isolated Systolic Hypertension with Type 2 Diabetes Patients

Ming Gao et al.

Summary: This study compared cardiovascular risks of four different antihypertensive drugs in patients with isolated systolic hypertension (ISH) and type 2 diabetes mellitus (T2DM). The results showed that angiotensin receptor blockers (ARB) reduced the risk of cardiovascular mortality, while other drugs did not have the same effect.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control

Cora E. Lewis et al.

Summary: Among patients at increased cardiovascular risk, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of major adverse cardiovascular events and all-cause mortality compared to targeting a systolic blood pressure of less than 140 mm Hg, both during the trial and post-trial follow-up. However, some adverse events were more frequent in the intensive-treatment group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Mathematical & Computational Biology

Propensity score weighting for causal subgroup analysis

Siyun Yang et al.

Summary: This article introduces analytical methods and visualization tools for causal subgroup analysis, including subgroup weighted average treatment effect and overlap weighting method. The proposed methods aim to achieve balance within subgroups and to address the bias-variance tradeoff in SGA. The Connect-S plot is designed for visualizing subgroup covariate balance.

STATISTICS IN MEDICINE (2021)

Article Pharmacology & Pharmacy

Renin-angiotensin system inhibitors and development of hepatocellular carcinoma: A systematic review and meta-analysis

Fereshteh Asgharzadeh et al.

CURRENT PHARMACEUTICAL DESIGN (2020)

Article Medicine, General & Internal

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial

Jeff D. Williamson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Geriatrics & Gerontology

The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer's Disease and Other Dementias in the United States

Julie M. Zissimopoulos et al.

JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES (2018)

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Article Medicine, General & Internal

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

Blanaid M. Hicks et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Public, Environmental & Occupational Health

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available

Miguel A. Hernan et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)

Article Mathematical & Computational Biology

Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis

Peter C. Austin

STATISTICS IN MEDICINE (2016)

Article Peripheral Vascular Disease

The His and Hers of the Renin-Angiotensin System

Lucinda M. Hilliard et al.

CURRENT HYPERTENSION REPORTS (2013)

Article Mathematical & Computational Biology

A Weighting Analogue to Pair Matching in Propensity Score Analysis

Liang Li et al.

INTERNATIONAL JOURNAL OF BIOSTATISTICS (2013)

Review Peripheral Vascular Disease

Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis

Natacha Levi Marpillat et al.

JOURNAL OF HYPERTENSION (2013)

Article Cardiac & Cardiovascular Systems

Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin-Angiotensin System Inhibitors

Harikrishna Makani et al.

AMERICAN JOURNAL OF CARDIOLOGY (2012)

Review Medicine, Research & Experimental

Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders

Juan M. Saavedra

CLINICAL SCIENCE (2012)

Article Neurosciences

Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation

Julius Benicky et al.

NEUROPSYCHOPHARMACOLOGY (2011)

Article Mathematical & Computational Biology

Multiple imputation using chained equations: Issues and guidance for practice

Ian R. White et al.

STATISTICS IN MEDICINE (2011)

Article Medicine, General & Internal

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

William C. Cushman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Public, Environmental & Occupational Health

Constructing inverse probability weights for marginal structural models

Stephen R. Cole et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)

Article Public, Environmental & Occupational Health

Evaluating medication effects outside of clinical trials: New-user designs

WA Ray

AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)